ClinicalTrials.Veeva

Menu

Horizons Chronic Graft-Versus-Host-Disease Study

University of Miami logo

University of Miami

Status

Active, not recruiting

Conditions

Graft Vs Host Disease
Quality of Life
Stem Cell Transplant Complications
Coping Skills

Treatments

Behavioral: Horizons Group Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06160986
20230656

Details and patient eligibility

About

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Enrollment

20 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • underwent allogeneic hematopoietic stem cell transplant
  • have moderate to severe chronic graft versus host disease
  • currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program
  • able to participate in a group intervention in English or Spanish language

Exclusion criteria

  • comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
  • vulnerable patients, defined here as prisoners and pregnant women

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Horizons Group
Experimental group
Description:
Participants will receive the Horizons Group intervention for up to 8 weeks.
Treatment:
Behavioral: Horizons Group Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Milan Pasic, BA; Lara Traeger, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems